ArticleBriefings in bioinformatics2025
RLEAAI: improving antibody-antigen interaction prediction using protein language model and sequence order information.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evidence-aware comparison of sequence-centric machine learning for antibody discovery and optimization.Briefings in bioinformatics · 2026Article
- Artificial intelligence advancements in monoclonal antibody development technology.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Antibody-antigen interactions (AAIs) are a pervasive phenomenon in the natural and are instrumental in the design of antibody-based drugs. Despite the emergence of various deep learning-based methods aimed at enhancing the accuracy of AAIs predictions, most of these approaches overlook the significance of sequence order information. In this study, we propose a new deep learning-based method RLEAAI, to improve the prediction performance of AAIs. In RLEAAI, a sequence order extraction strategy, called Composition of K-Spaced Amino Acid Pairs, is employed to generate feature representation from the feature embedding outputted by a pre-trained protein language model. In order to fully dig out the discrimination information from features, three neural network modules, i.e. convolutional neural network, bidirectional long short-term memory network and recurrent criss-cross attention mechanism, are integrated. Benchmarked results on two independent test sets demonstrate that RLEAAI is capable of achieving an average accuracy of 0.7787 and an average Matthews's correlation coefficient (MCC) value of 0.5552, representing a 5.2% and 15.8% improvement over the start-of-the-art method DeepAAI. Furthermore, the complementary determining regions-sensitivity value calculated on MCC of RLEAAI is 216.4% higher than that of the state-of-the-art method DeepAAI. The standalone package of RLEAAI is freely available at https://github.com/zhouyu9931/RLEAAI.git.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.